Topoisomerase I Inhibitors Pair With PARP Drugs Against Resistant Ovarian Cancer
A screen of over 1400 FDA-approved compounds identified topoisomerase I inhibitors as the most effective partners for PARP inhibitors in ...
Tag: drug combination
Telotristat Plus Everolimus Halts Tumor Growth in Neuroendocrine Cancer Models
A preclinical study reports that combining the serotonin-synthesis inhibitor telotristat ethyl with the mTOR inhibitor everolimus arrested tumor growth in ...
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development